跳至主要内容
临床试验/IRCT20150101020514N26
IRCT20150101020514N26尚未招募2 期

A single-arm, before- after clinical study to evaluate the safety and efficacy of Inshape X® intradermal filler containing 150mg poly-L-lactic acid (NanoDaru Pajuhan Pardis) for correction of moderate to severe nasolabial folds

ano Darou Pajouhan Pardis Company0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 18–65-year-old men and women
  • Moderate to severe nasolabial folds based on Allergan criteria.
  • The opportunity to accompany the visit programs and study process.
  • Signing the informed consent form and agree to a 6-month follow-up.

排除标准

  • History of type 1 allergic reactions or anaphylaxis reactions
  • Previous allergy to filler and lidocaine ingredients
  • History of hypertrophic and colloid scars or bleeding disorders in the nasolabial region
  • Active inflammatory processes, infection, lesion (cancerous/noncancerous) in the nasolabial region
  • Pregnancy and lactation

研究者

发起方
ano Darou Pajouhan Pardis Company

相似试验